Prednisolone

Patients with sarcoidosis receiving 40 mg per day of prednisolone had comparable rates of treatment failure and adverse effects to patients receiving 20 mg per day, according to a European Respiratory Society International Congress presentation.

Mycophenolate mofetil was superior to azathioprine in achieving biochemical remission in treatment-naive patients with autoimmune hepatitis who were also treated with prednisolone, according to data presented at EASL Congress.

Personalized point-of-care eosinophil-guided oral prednisolone therapy in primary care was safe and did not worsen outcomes in individuals with COPD exacerbations, researchers reported at the European Respiratory Society International Congress.

Add-on low-dose prednisolone improves long-term disease activity and progression in senior patients with established rheumatoid arthritis, albeit with an increase in non-severe adverse events, according to data.

Prolonged initial prednisolone therapy does not significantly alter the disease course in young children with nephrotic syndrome, according to a speaker at ASN Kidney Week.

In this video, Ben Tran, MD, discusses the PEACE-1 and STAMPEDE studies that looked at the addition of abiraterone acetate plus prednisolone (AAP) to standard therapy, which was found to improve survival vs. standard therapy.

Long-term azithromycin treatment increased lumen radius and lumen area in patients with severe persistent asthma, but did not affect bronchial wall thickness, according to new data published in Respiratory Medicine.

Amoxicillin/clavulanate plus prednisolone in severe alcoholic hepatitis do not improve survival at 2 months, according to a presentation at the International Liver Congress.

In this Healio Video Perspective from the virtual AAO annual meeting, John A. Hovanesian, MD, FACS, discusses results from a study investigating patient experience with a minimum drop regimen following cataract surgery.